Sartorius | SRT3 - PE Price to Earnings


Sartorius reported 52.99 in PE Price to Earnings for its fiscal quarter ending in June of 2026.





Pe Change Date
Akebia Therapeutics 1.63K 1.6K Dec/2025
Dianthus Therapeutics 3.8 1.53 Sep/2024
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
IQVIA Holdings 21.45 2.08 Jun/2026
Moderna 27.22 14.51 Jun/2023
Organon & Co 8.32 4.57 Mar/2026
Revvity 36.47 5.68 Jun/2026
Sartorius 52.99 9.56 Jun/2026
Tectonic Therapeutic 4.01 0.63 Mar/2024
Viatris 14.61 4.21 Mar/2026
Xeris Pharmaceuticals 76.05 2.37K Mar/2026